Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-03-10

Clinical Trial Update: Belinostat Therapy With Zidovudine for Adult T-Cell Leukemia-Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating belinostat in combination with zidovudine for adult T-cell leukemia/lymphoma has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BELEODAQ (BELINOSTAT)
  • RETROVIR (Zidovudine)

Snippet

Sponsor: University of Miami | Conditions: Adult T-cell Leukemia-Lymphoma, ATLL | Phase 2 | Status: COMPLETED | Results posted: 2026-03-10